NCT07912138Not yet recruiting
Effectiveness of High-intensity Peripheral Magnetic Stimulation on Hemiplegic Shoulder Pain After Stroke
Effectiveness of High-intensity Peripheral Magnetic Mtimulation in Patients With Post-stroke Hemiplegic Shoulder Pain
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
This study aims to investigate the effectiveness of high-intensity electromagnetic stimulation using the BTL-6000 Super Inductive System (SIS) in the management of hemiplegic shoulder pain in patients with stroke. Hemiplegic shoulder pain is a common complication following stroke and may negatively affect upper limb function, participation in rehabilitation, and quality of life. The study will evaluate whether treatment with the Super Inductive System can reduce shoulder pain and improve shoulder-related clinical outcomes. The findings are expected to contribute to the evidence regarding non-invasive physical therapy approaches for hemiplegic shoulder pain.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 21 Oct 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 1 Aug 2027
- Lead sponsor
- Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Diseases
- Stroke
- NCT number
- NCT07912138
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Nov 2026 to the primary completion date, 1 Aug 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Shoulder injection within the previous 3 months.
- Previous treatment with high-intensity laser therapy, electromagnetic stimulation, or therapeutic ultrasound.
- Pacemaker, implanted electronic device, or metallic implant contraindicating electromagnetic stimulation.
Other illness
- Shoulder pain or restricted shoulder movement before the stroke.
- History of shoulder trauma, infection, malignancy, or surgery.
- Central post-stroke pain or complex regional pain syndrome.
- Cervical radiculopathy or another neurological disorder.
- Inflammatory rheumatic disease.
- Severe aphasia or severe visual or hearing impairment.
Lab values
- Uncontrolled diabetes mellitus (HbA1c of 8% or higher or poor glycemic regulation within the previous 3 months).
Other
- Full-thickness rotator cuff tear.
- Modified Ashworth Scale (MAS) score of 3 or higher.
- Pregnancy.
Who the study is looking for
- Adults aged 18-75 years.
- History of a first-ever unilateral stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), occurring more than 3 months before enrollment.
- Hemiplegic shoulder pain with a Visual Analog Scale (VAS) score of at least 4.
- Presence of shoulder pathology identified by clinical examination and ultrasonography.
- Reduced shoulder range of motion.
- Brunnstrom recovery stage of at least 2.
- Clinically stable condition.
- Mini-Mental State Examination (MMSE) score of at least 18.
- Ability to provide written informed consent.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.